scispace - formally typeset
L

Liusheng Huang

Researcher at University of California, San Francisco

Publications -  54
Citations -  1396

Liusheng Huang is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Dihydroartemisinin & Lumefantrine. The author has an hindex of 20, co-authored 54 publications receiving 1239 citations. Previous affiliations of Liusheng Huang include Karolinska Institutet & University of Iowa.

Papers
More filters
Journal ArticleDOI

Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

Elizabeth A. Ashley, +51 more
- 18 Sep 2015 - 
TL;DR: Higher, more frequent, or prolonged dosage regimens should now be evaluated in very young children, particularly if malnourished, and in patients with hyperparasitemia, as well as patients in very low transmission intensity areas with emerging parasite resistance.
Journal ArticleDOI

Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.

TL;DR: Exposure to DHA, but not LR, was significantly lower during EFV-AL co-administration compared with that during administration of AL alone, and these findings may have implications for the treatment efficacy of AL, particularly in children.
Journal ArticleDOI

Role of heme-protein covalent bonds in mammalian peroxidases. Protection of the heme by a single engineered heme-protein link in horseradish peroxidase

TL;DR: It is unambiguously demonstrated that a single heme-protein link is sufficient to protect the heme from vinyl group modification even in a protein (HRP) that is normally highly susceptible to this reaction.
Journal ArticleDOI

In vitro metabolism of piperaquine is primarily mediated by CYP3A4.

TL;DR: The extent of inhibition of in vitro metabolism with ketoconazole (83%) denotes that PQ appears to be primarily catalyzed by CYP3A4, and further studies to support these findings through the identification and characterization of PQ metabolites are planned.